Castle Biosciences Corp (CSTL) - Prakiraan wutah bathi saben saham kanggo taun ngarep

Castle Biosciences (CSTL) leverages unique DecisionDx patents to create a powerful defensive moat, which illustrates the trend of earnings per share growth forecasts, where 27.00 forms the current metric value. The business relies on a dermato-oncology molecular ecosystem characterized by high switching costs. Stability is provided by specialized US laboratories whose high-precision tests are integrated into clinical skin cancer diagnostic standards.

Castle Biosciences Inc (CSTL): Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep saka 04.07.2022 nganti 12.11.2026

CSTL (castlebiosciences.com): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:

Bagan rega Castle Biosciences Corp|CSTL - Bagan rega target

- indikator kapitalisasi pasar:

Biji pasar Castle Biosciences|CSTL - Total Nilai Perusahaan

- informasi kapitalisasi buku:

Aset Bersih saben Siji Saham Castle Biosciences|CSTL - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku castlebiosciences.com|CSTL - Gunggung Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Utang marang Ekuitas Castle Biosciences|CSTL - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Castle Biosciences, Inc.|CSTL - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Castle Biosciences|CSTL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Castle Biosciences|Indikator likuiditas cepet castlebiosciences.com

- data bathi resik lan rasio valuasi:

CSTL - Bathi sawise mbayar pajeg|Bathi sing dikarepake Castle Biosciences|CSTL - Rasio rega marang bathi|Pangali Forward P/E Castle Biosciences|CSTL - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Castle Biosciences|CSTL - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Castle Biosciences|CSTL - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan castlebiosciences.com|CSTL - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Castle Biosciences

Analisis komprehensif perusahaan:Castle Biosciences Corp, CSTL

For Castle Biosciences (CSTL), a developer of AI-driven skin cancer diagnostics, the consensus forward EPS growth rate reflects market expectations for the scaling of genomic tests. This metric is calculated as the percentage change in expected earnings per share over the next four quarters, allowing investors to assess the monetization potential of innovations and the overall resilience of the company's business model.

Pesaing utama